Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Apr 25:8:168-172.
doi: 10.1016/j.bonr.2018.04.009. eCollection 2018 Jun.

Adults with osteogenesis imperfecta: Clinical characteristics of 151 patients with a focus on bisphosphonate use and bone density measurements

Affiliations

Adults with osteogenesis imperfecta: Clinical characteristics of 151 patients with a focus on bisphosphonate use and bone density measurements

Luuk J J Scheres et al. Bone Rep. .

Erratum in

Abstract

An expert center for adults with Osteogenesis Imperfecta (OI) has been founded at the Isala Hospital in Zwolle, the Netherlands to achieve optimal care for adults with OI. Clinical data such as patient history, Dual Energy X-ray Absorptiometry measurements and laboratory findings are collected with patient consent. This study provides an overview of clinical characteristics of the patients who visited the clinic during its first 5 years, a total of 151 patients. In this study, we focus on bisphosphonate use and bone density measurements at time of presentation at the expert center. As such, insight into the natural history of OI in adults will be increased. Analysing the data of a large group of adults with this rare disorder within a national expert center will allow detailed exploration of the course of OI over time.

Keywords: Adult; Bisphosphonates; Bone density; Expert center; Fractures; Osteogenesis imperfecta.

PubMed Disclaimer

References

    1. Clarke B. Normal bone anatomy and physiology. Clin. J. Am. Soc. Nephrol. 2008;3(Suppl. 3):131–139. - PMC - PubMed
    1. van Dijk F.S., Sillence D.O. Osteogenesis imperfecta: clinical diagnosis, nomenclature and severity assessment. Am. J. Med. Genet. A. 2014 Jun;164A(6):1470–1481. - PMC - PubMed
    1. Dwan K., Phillipi C.A., Steiner R.D., Basel D. Bisphosphonate therapy for osteogenesis imperfecta. Cochrane Database Syst. Rev. 2016;10:CD005088. - PMC - PubMed
    1. Glorieux F.H., Bishop N.J., Plotkin H., Chabot G., Lanque G., Travers R. Cyclic Administration of Pamidronate in children with severe. N. Engl. J. Med. 1998;339(14):947–952. - PubMed
    1. Hald J.D., Folkestad L., Harsløf T., Lund A.M., Duno M., Jensen J.B., Neghabat S., Brixen K., Langdahl B. Skeletal phenotypes in adult patients with osteogenesis imperfecta-correlations with COL1A1/COL1A2 genotype and collagen structure. Osteoporos. Int. 2016;27(11):3331–3341. - PubMed

LinkOut - more resources